Search

everythinglearnresearchcommunity

for

Search:↓

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

The patient had complex urinary tract issues and ambiguous genitalia, with physical features suggesting a hormonal imbalance.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Medicalizing male and female bodies can have negative impacts.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Proper management of the dilation program is crucial after male-to-female reassignment surgery.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

70% of women with androgenetic alopecia can have successful hair transplants.

A woman developed male characteristics after using unregulated hormone therapy.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.